Autism gets fine diuretic diagnosis

Advanced Search

The story appears on

Page A4

February 23, 2021

GET this page in PDF

Free for subscribers

View shopping cart

Autism gets fine diuretic diagnosis

By Cai Wenjun | 00:00 UTC+8 February 23, 2021 |

Print Edition

Research by doctors from Shanghai’s Xinhua Hospital and experts from Fudan University and Cambridge University has found that a common pediatric diuretic has positive effects on autism.

Autism, a developmental disorder that can cause communication and behavioral problems, usually develops at the age of 3 and can be a life-long condition. About 1 percent of the world’s population suffers from autism. Treatment is mainly behavior intervention, as there is no medication that has a good effect.

But behavior intervention is in short supply. Even in developed countries only 20 percent of children can receive intervention and direction after being diagnosed for one year.

Effective medication is badly needed, especially for young children whose neurons are still developing, experts say.

“Bumetanide is a common pediatric diuretic, which is cheap, mild and has slight side effects,” said Dr Li Fei from Xinhua Hospital, leading expert in the research.

“Through non-invasive magnetic resonance spectroscopy technology, we conducted a clinical trial by using bumetanide on autistic children between 3 and 6 years old. Those taking the medicine for three months had a great improvement in communication and perception and the medicine is safe and effective.”

Metro

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Autism gets fine diuretic diagnosis

Email this to your friend